The co-expressed IL-15/IL-15Rα complex could prolong the proliferation and survival of NKG2D CAR-T cells, resulting in superior anti-tumor and antiviral effects in EBV-PTLD models. This evidence concerns the gene IL15 and post-transplant lymphoproliferative disease.